SCHEMBL7073837

SCHEMBL7073837

COC(=O)CC(CS(=O)(=O)c1ccc(Oc2ccc(NC(N)=S)cc2)cc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 9/20 0.52
FNTB P49356 9/20 0.52
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44
CYP2C19 P33261 1/20 0.44
EPHX1 P07099 1/20 0.44
MMP13 P45452 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
MMP2 P08253 2/20 0.42
MMP9 P14780 2/20 0.42
MMP8 P22894 2/20 0.42
MMP14 P50281 2/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078814 0.85 MMP13 (0.48) FNTAFNTBALDH1A1MMP13MMP2
SCHEMBL7078927 0.81 CA12 (0.44) FNTAFNTBALDH1A1CYP2D6CYP2C9
SCHEMBL7077971 0.81 MMP13 (0.44) FNTAFNTBALDH1A1MMP13MMP2
SCHEMBL7078648 0.81 FNTA (0.54) FNTAFNTBALDH1A1MMP13MAPK1
SCHEMBL7077839 0.80 KDM4E (0.43)
SCHEMBL7073376 0.78 ALDH1A1 (0.46) ALDH1A1MMP13CA12CA9MMP2
SCHEMBL7079124 0.77 ALDH1A1 (0.45) FNTAFNTBALDH1A1MMP13MMP2
SCHEMBL7079059 0.77 ALDH1A1 (0.45) FNTAFNTBALDH1A1CYP3A4CYP2D6
SCHEMBL7078136 0.77 MMP2 (0.58) FNTAFNTBCA12CA1CA2
SCHEMBL7079922 0.77 MMP2 (0.43) FNTAFNTBALDH1A1MMP13MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed